These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Yu SJ; Kim W; Kim D; Yoon JH; Lee K; Kim JH; Cho EJ; Lee JH; Kim HY; Kim YJ; Kim CY Medicine (Baltimore); 2015 Dec; 94(48):e2159. PubMed ID: 26632897 [TBL] [Abstract][Full Text] [Related]
23. Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway. Kumagai H; Sasaki A; Umemura A; Kakisaka K; Iwaya T; S Nishizuka S Endocr J; 2024 Feb; 71(2):139-152. PubMed ID: 38171883 [TBL] [Abstract][Full Text] [Related]
24. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease. Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030 [TBL] [Abstract][Full Text] [Related]
25. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. D'Incao RB; Tovo CV; Mattevi VS; Borges DO; Ulbrich JM; Coral GP; Ramos MJ; Meinhardt NG Obes Surg; 2017 Aug; 27(8):2151-2158. PubMed ID: 28281237 [TBL] [Abstract][Full Text] [Related]
26. Changes in Hepatic Fat Content by CT 1 Year After Sleeve Gastrectomy in Adolescents and Young Adults With Obesity. López López AP; Tuli S; Lauze M; Becetti I; Pedreira CC; Huber FA; Omeroglu E; Singhal V; Misra M; Bredella MA J Clin Endocrinol Metab; 2023 Nov; 108(12):e1489-e1495. PubMed ID: 37403207 [TBL] [Abstract][Full Text] [Related]
27. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy. Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052 [TBL] [Abstract][Full Text] [Related]
28. Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity. Ceccarelli V; Barchetta I; Cimini FA; Bertoccini L; Chiappetta C; Capoccia D; Carletti R; Di Cristofano C; Silecchia G; Fontana M; Leonetti F; Lenzi A; Baroni MG; Barone E; Cavallo MG Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260451 [TBL] [Abstract][Full Text] [Related]
29. Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy. Ma B; Sun H; Zhu B; Wang S; Du L; Wang X; Qu S Obes Facts; 2021; 14(1):64-71. PubMed ID: 33352578 [TBL] [Abstract][Full Text] [Related]
30. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study. Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336 [TBL] [Abstract][Full Text] [Related]
31. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease. Gaddipati R; Sasikala M; Padaki N; Mukherjee RM; Sekaran A; Jayaraj-Mansard M; Rabella P; Rao-Guduru V; Reddy-Duvvuru N Ann Hepatol; 2010; 9(3):266-70. PubMed ID: 20720266 [TBL] [Abstract][Full Text] [Related]
32. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice. Wu Z; Tan J; Chi Y; Zhang F; Xu J; Song Y; Cong X; Wu N; Liu Y Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G659-G670. PubMed ID: 29902065 [TBL] [Abstract][Full Text] [Related]
33. A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents. Kursawe R; Dixit VD; Scherer PE; Santoro N; Narayan D; Gordillo R; Giannini C; Lopez X; Pierpont B; Nouws J; Shulman GI; Caprio S Diabetes; 2016 Mar; 65(3):610-8. PubMed ID: 26718495 [TBL] [Abstract][Full Text] [Related]
34. A multidisciplinary approach to laparoscopic sleeve gastrectomy among multiethnic adolescents in the United States. Jaramillo JD; Snyder E; Farrales S; Stevens M; Wall JK; Chao S; Morton J; Pratt JS; Hammer L; Shepard WE; Bruzoni M J Pediatr Surg; 2017 Oct; 52(10):1606-1609. PubMed ID: 28697852 [TBL] [Abstract][Full Text] [Related]
35. A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity. Osorio-Conles Ó; Vega-Beyhart A; Ibarzabal A; Balibrea JM; Graupera I; Rimola J; Vidal J; de Hollanda A Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638880 [TBL] [Abstract][Full Text] [Related]
36. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214 [TBL] [Abstract][Full Text] [Related]
37. Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity. Rachakonda V; Wills R; DeLany JP; Kershaw EE; Behari J Obesity (Silver Spring); 2017 Aug; 25(8):1360-1368. PubMed ID: 28605159 [TBL] [Abstract][Full Text] [Related]